Thor Medical ASA (OSL:TRMED)
kr 1.018 0.014 (1.39%) Market Cap: 239.09 Mil Enterprise Value: 210.39 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 39/100

Q3 2021 Nordic Nanovector ASA Earnings Call Transcript

Nov 18, 2021 / 07:30AM GMT
Release Date Price: kr25.86 (-7.81%)
Erik Skullerud
Nordic Nanovector ASA - CEO

(technical difficulty)

So I started my career in Bayer, worked mainly in Scandinavia but was situated in Sweden back then. Seven years later, I moved to Amgen, moved also to Switzerland and spent about 16, almost 17 years with that company in different positions around the world. I've done everything from strategic marketing roles, worked in different therapeutic areas, oncology, in bone disease, nephrology, in cardiovascular. But I've also been in different countries in management roles. As an example, Australia. I've been in the Netherlands, I've been in Greece. So I've become a little bit of a global nomad as far as my personal life is concerned. I have a wife and 2 kids. They are born outside the country. So as much as it pleases me every time I get to go back to Norway, I also have a life outside due to an international family. So in that sense, great to come back and be part of a Norwegian company. And also want to talk a little bit on why I've joined Nordic Nanovector. First of all, I think we could all agree that this is exciting time for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot